Melatonin is a hormone naturally produced by the pineal gland in humans and regulates circadian rhythms and sleep-wake cycles. It is commonly used as a dietary supplement to promote sleep, reduce jet lag, and manage insomnia. Melatonin supplements are available in various forms including capsules, tablets, liquids, and edibles. The increasing prevalence of insomnia and other sleep disorders has driven the demand for sleep aids like melatonin.
The global Melatonin Market is estimated to be valued at Us$ 576.85 Mn in 2023 and is expected to exhibit a CAGR Of 7.2% over the forecast period 2023 To 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
The melatonin market is expected to witness significant growth over the forecast period, owing to the increasing prevalence of insomnia. Insomnia is one of the most common sleep disorders affecting people of all age groups across the globe. Symptoms of insomnia include difficulty falling asleep, waking up frequently during the night, and waking up too early in the morning. As per the estimates of National Sleep Foundation, nearly 50-70 million Americans are affected by insomnia every year. Moreover, according to International Classification of Sleep Disorders-3, the prevalence of chronic insomnia disorder is 10% among adults. Growing consumer inclination towards self-medication and adoption of natural sleep aids like melatonin supplements due to the concerns regarding side-effects of prescription drugs is another major factor fueling the market growth. Furthermore, rising emphasis on better sleep quality and increasing awareness about insomnia and sleep hygiene are expected to propel melatonin demand over the forecast period.
SWOT Analysis
Strength: Melatonin has strong therapeutic applications, especially for treating insomnia and sleep disorders. It helps induce sleepiness and regulate the sleep-wake cycle. It also improves symptoms of jet lag and improves sleep for those who work night shifts. Melatonin is a natural compound that is generally safe and has relatively low risk of side effects. Its natural origin gives it acceptance among those preferring natural remedies.
Weakness: Melatonin supplements are not strongly regulated and quality and dosage consistency can vary between manufacturers. Too high of a dose can potentially cause daytime drowsiness or irritability. Scientific evidence is still evolving regarding its long term safety. Some groups like pregnant women should use it only after consulting a medical practitioner.
Opportunity: Growing awareness about how inadequate sleep impacts health and well-being presents major market opportunities. As more people lead stressful lives and suffer from poor sleep habits, demand for safe and effective sleep aids will increase. The rising elderly population susceptible to sleep issues also expands growth prospects. Technological innovations can make melatonin delivery more convenient through formulations like gummies, beverages, or timed-release pills.
Threats: Strict regulations capping doses or tightening supplement guidelines can restrict the market. Some countries have banned its over-the-counter sales. Competition from established prescription sleep medications and other natural substitutes also pose threats. Economic downturns impacting discretionary spends on supplements can reduce demand.
Key Takeaways
The Global Melatonin Market Demand is expected to witness high growth over the forecast period of 2023-2030. Rising lifestyle-related health issues negatively impacting sleep along with growing demographic of elderly population are driving demand. Oral formulations still dominate sales but innovations in delivery formats are expanding use cases.
Regional analysis
North America currently dominates the market owing to high healthcare expenditures and more receptive regulatory environment for supplements. However, Asia Pacific is poised to showcase fastest growth rate due to rising health awareness, large population base and expanding middle class demographic seeking sleep aids. China and India are emerging as lucrative markets given their huge population sizes and improving disposable incomes.
Key players
Key players operating in the melatonin market are Natrol Inc., Neurim Pharmaceuticals Ltd., Pulse Pharmaceuticals Pvt. Ltd., Flynn Pharma Ltd., Fidia Farmaceutici S.P.A., Aspen Pharmacare Holdings Ltd., Schiff Nutrition International Inc., Solal Technologies (Pty) Ltd., Rexall Sundown, Inc., and Bebida Beverage Co. These companies are focused on expanding their product portfolios and entering new regional markets through partnerships and mergers and acquisitions.
Get more insights on this topic :
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian